The global cancer biomarkers market was valued at US$ 27.8 billion in 2025 and is projected to reach US$ 100.9 billion by 2036, expanding at a CAGR of 12.3% during the forecast period from 2026 to 2036. Market growth is driven by the increasing prevalence of cancer worldwide, rising adoption of precision medicine, advancements in genomic and proteomic technologies, growing demand for ... https://www.transparencymarketresearch.com/cancer-biomarkers-market.html